StonvexLoading…
StonvexStonvexStonvexCore line items from LGND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $268.09M | $167.13M | $131.31M | $196.25M |
Operating Income | $41.00M | $-22.61M | $11.94M | $3.04M |
Net Income | $124.45M | $-4.03M | $52.15M | $-33.36M |
EPS (Diluted) | $6.13 | $-0.22 | $2.94 | $-1.98 |
Total Assets | $1.56B | $941.77M | $787.22M | $762.67M |
Total Liabilities | $543.42M | $111.33M | $86.30M | $165.18M |
Cash & Equivalents | $174.93M | $72.31M | $22.95M | $45.01M |
Free Cash Flow OCF − CapEx | $48.91M | $95.23M | $46.06M | $119.93M |
Shares Outstanding | 19.77M | 19.11M | 17.56M | 16.95M |